Differences in identification of patients’ deterioration may hamper the success of clinical escalation protocols
Ashley J.R. De Bie(Radboud University Nijmegen), Kerian O’Mahony, Eilish Croke, Chris Hancock, R. Arthur Bouwman(Amsterdam UMC Location Vrije Universiteit Amsterdam), Paul Barach(Massachusetts General Hospital), Jillian Hartin(University College London Hospitals NHS Foundation Trust), Dorothy Breen(Cork University Hospital), Alexander J. G. H. Bindels(University Medical Center Utrecht), Mark Holland, Tim Cooksley(The Christie NHS Foundation Trust), Christian P Subbe(Bangor University), Declan Byrne, Peter Donnelly(Torbay and South Devon NHS Foundation Trust), H.H.M. Korsten(Radboud University Nijmegen), Seán Kennelly(Trinity College Dublin), Rick Bezemer(Radboud University Nijmegen), Dirk Hueske-Kraus, Rebecca Lunn, Denise Hinge, Helene Beaugrand, Lesley Durham, Clodagh O’Dwyer, Michael Müller(University of Freiburg), E Davis, Rohan Goel, Catriona Chalmers, Geoffrey K. Lighthall, Eímhín Dunne, John Kellett(Hospital South West Jutland), Bryn Ellis, Hayley Cleaver
Cited by 8
Related Papers
A global reference for human genetic variation
|Nature|2015|20.3k
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
|Nature|2007|9.7k
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
|Nature|2011|2.8k
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis
|Nature Genetics|2013|1.5k